《新股消息》據報內地化妝品企業上美集團最快今年來港上市
外電引述消息指,內地化妝品企業上美集團劃最快於今年在香港進行首次公開發售(IPO),目標在未來幾個星期內提交上市申請,現時正與中金公司、中信証券及摩根大通等磋商來港上市計劃,或集資數億美元。
消息人士指,集資金額及上市時間表等發行細節仍處於初步商討階段。早前有消息指,上美集團此前曾考慮在上海證券交易所上市,後來決定將上市計劃轉移到香港。
官網資料顯示,上美集團成立於2002年,擁有韓束、一葉子、紅色小象等內地化妝品品牌,於2015年進行A輪融資,引入中信資本及聯新資本等投資者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.